TABLE 1.
MAb | Half-maximal binding toa:
|
P value | |
---|---|---|---|
V3-FP | V3 peptide | ||
2182 | 0.02 ± 0.01 | 0.14 ± 0.03 | 0.071 |
2191 | 0.04 ± 0.02 | 0.83 ± 0.09 | 0.015 |
2219 | 0.02 ± 0.01 | 0.84 ± 0.16 | 0.036 |
2412 | 0.02 ± 0.01 | 2.21 ± 0.01 | 0.0001 |
2442 | 0.02 ± 0.01 | 1.40 ± 0.2 | 0.02 |
2456 | 0.03 ± 0.02 | 2.10 ± 0.4 | 0.035 |
447-52Db | 0.01 ± 0.01 | 0.16 ± 0.07 | 0.17 |
ELISA plates coated with V3-FP and V3 peptide at 59 nM concentration; mean of two experiments (micrograms per milliliter ± standard deviation).
Control human anti-V3 MAb selected with V3MN peptide.